Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Drug Induced Liver Disease
How would you approach the management of drug-induced autoimmune hepatitis compared to non-drug-induced autoimmune hepatitis?
Related Questions
When do you pursue liver biopsy for assessment of DILI?
How do you counsel patients on the use and risks of alternative medications and supplements given how prevalent and easily accessible they are to the average person?
How do you utilize urine sodium and potassium levels and ratios in diuretic optimization in patients with ascites?
What testing do you utilize to decide a patient's candidacy for Resmetirom therapy?
In what scenarios do you defer treatment of a patient's hepatitis C if they are undergoing liver transplant evaluation?
What kind of monitoring do you choose in patients at risk for reactivation of hepatitis B who are on immunosuppression?
How do you incorporate palliative care specialists into the care of patients with chronic liver disease, especially those who may not be transplant candidates?
Do you obtain liver biopsy to confirm the diagnosis of cirrhosis if cirrhotic liver morphology is noted on imaging?
What role do you see for albumin infusions in patients with hypoalbuminemia to help assist in volume status, outside of its use in replenishment after a large volume paracentesis or renal dysfunction?
How do you approach a patient who has incidentally found liver and renal cysts?
